As of April 15, 2025, Nuvalent (NUVL) has a market cap of $5.07 billion USD. According to our data, Nuvalent is ranked No.2527 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $5.07 B |
-1.34%
|
Dec 31, 2024 | $5.14 B |
6.37%
|
Dec 29, 2023 | $4.83 B |
147.11%
|
Dec 30, 2022 | $1.95 B |
56.41%
|
Dec 31, 2021 | $1.25 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
![]() USA
|
![]() Relay Therapeutics
RLAY
|
$0.47 B |
-0.000 M
|
![]() USA
|
![]() Revolution Medicines
RVMD
|
$6.75 B |
0.000 M
|
![]() USA
|
![]() Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
![]() USA
|
![]() Zentalis Pharmaceuticals
ZNTL
|
$91.20 M |
0.000 M
|
![]() USA
|
![]() Kura Oncology
KURA
|
$0.49 B |
0.000 M
|
![]() USA
|
![]() Cogent Biosciences
COGT
|
$0.55 B |
-0.000 M
|
![]() USA
|
![]() G1 Therapeutics
GTHX
|
$0.38 B |
0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.06 B |
-0.000 M
|
![]() USA
|
Market Cap | = | NUVL Stock Price | * | NUVL Shares Outstanding |
= | $70.78 | * | 66.16 M | |
= | $5.07 B |